尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Aminov Erez. Officer active across 2 companies, notably MIRA PHARMACEUTICALS, INC.. Aggregated, 5 reports have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €75k. History available since 21 May 2024. The latest transaction was disclosed on 22 April 2026 (J). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Aminov Erez is Chief Executive Officer at MIRA PHARMACEUTICALS, INC. (XNAS) and CEO and Chairman at Telomir Pharmaceuticals, Inc. (XNAS). He is associated with 5 filings in total, and across the 5 sampled recent filings the reported buy and sell amounts are EUR 1842 and EUR 72695, from 2024-05-22 to 2026-04-24, with the modal transaction nature shown as Attribution.